StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.01 (-1.40%)

Close on Nov 18, 2026Market cap $1.27MP/E –Yield –

Scinai Immunotherapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Scinai Immunotherapeutics's price to book ratio was 0.2× on Nov 11, 2026, against 2.0× a year earlier. Over the last 3 years it ranged from 0.2× to 312.3×, with a median of 2.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.2×−1.1
2025Dec 31, 20251.4×−9.9
2023Jan 31, 202311.3×−1.5
2022Dec 30, 202212.8×–

More Scinai Immunotherapeutics figures

See a number that looks wrong?